Prosthetic valve delivery system including retrograde/antegrade approach

Information

  • Patent Grant
  • 8808367
  • Patent Number
    8,808,367
  • Date Filed
    Friday, September 7, 2007
    17 years ago
  • Date Issued
    Tuesday, August 19, 2014
    10 years ago
Abstract
A device for implanting an expandable heart valve prosthesis at a valve annulus in a patient's heart includes an implantation device configured to extend from a first opening in the patient's body, through the patient's aorta, through a valve annulus, through an opening in a ventricle, and to exit through the patient's thoracic region. The device further includes a port having a hemostasis valve for providing access through the patient's thoracic region and into the ventricle and at least two interchangeable modules configured for delivery using the implantation device.
Description
TECHNICAL FIELD

The present invention relates generally to methods and systems for cardiovascular surgery. More particularly, the invention relates to methods and systems for the repair, removal and/or replacement of heart valves.


BACKGROUND

Minimally-invasive percutaneous valve replacement procedures have emerged as an alternative to open-chest surgery, using intravascular catheterization (e.g., from a femoral artery access point) or a minimally-invasive surgical technique. Because the minimally-invasive approach requires only a small incision, it allows for a faster recovery for the patient with less pain and bodily trauma. This, in turn, reduces the medical costs and the overall disruption to the life of the patient.


An inherent difficulty in the minimally-invasive percutaneous approach is the limited space that is available within the vasculature. Unlike open heart surgery, minimally-invasive heart surgery offers a surgical field that is only as large as the diameter of a blood vessel. Consequently, the introduction of tools and prosthetic devices is challenging. The device must be dimensioned and configured to permit it to be introduced into the vasculature, maneuvered therethrough, and positioned at a desired location. Moreover, lesions located in the vasculature may be a contraindication for certain types of delivery systems using femoral access.


Thus, there is a need in the art for methods and devices for performing heart valve repair and replacement, as well as other procedures within the heart and great vessels that provide greater ease of access to native heart valves.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a cross-sectional view of a human heart including a prosthetic heart valve.



FIG. 2 is a schematic view of the left side of the heart including an implantation device according to an embodiment of the present invention.



FIG. 3 is a schematic view of the left side of the heart including an implantation device and one interchangeable module according to an embodiment of the present invention.



FIGS. 4A and 4B are schematic views of the of the left side of the heart including an implantation device and another interchangeable module according to another embodiment of the present invention.



FIG. 5 is a schematic view of the left side of the heart including an implantation device and two interchangeable modules according to yet another embodiment of the present invention.



FIG. 6 is a schematic view of the left side of the heart including an implantation device and yet another interchangeable module according to yet another embodiment of the present invention.





While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION


FIG. 1 is a cross-sectional view of a human heart 2 with an expandable prosthetic heart valve 6 implanted within or adjacent an aortic valve annulus 10. Blood flows from the superior and inferior vena cavas 14 into a right atrium 18 of the heart 2 and then flows through a tricuspid valve 22 into a right ventricle 26. A pulmonary valve 30 facilitates blood flow from the right ventricle 26 to the pulmonary arteries 34. The blood is then oxygenated by the lungs and returned back to the heart via pulmonary veins 38. A mitral valve 42 then facilitates blood flow from a left atrium 46 to a left ventricle 50. Blood then flows from the left ventricle 50, through the aortic valve annulus 10, to the aorta 54. The aorta 54 then delivers the blood to the coronary arteries and the peripheral vascular system.


Using techniques well known to those of skill in the art, access to the heart 2, according to some embodiments, is established percutaneously through the aorta, femoral, radial or brachial arteries using a retrograde approach to reach a target site within the heart 6 (e.g. the aorta 54 or aortic valve annulus 10). Likewise, according to some embodiments, access to the aortic valve annulus is accomplished using a retrograde, minimally-invasive surgical technique to provide access to the aortic valve annulus 10 through an opening in the aortic arch.


Alternatively, according to various embodiments, access to the heart 2 and the aortic valve annulus 10 is established through the apical area 60 (e.g., apex) of the heart. In these embodiments, a percutaneous access port may be established through a patient's chest wall and into the left ventricle at or near the apex 60. According to some embodiments, access to the left ventricle 50 through the apex 60 is established using one of the methods and devices generally shown and described in U.S. Pat. No. 6,010,531, entitled “Less-invasive Devices and Methods for Cardiac Valve Surgery”, which is incorporated herein by reference.


The apex 60 of the heart 2 is generally the blunt rounded inferior extremity of the heart 2 formed by the left and right ventricles, 26 and 50. In normal healthy humans, the apex 60 generally lies behind the fifth left intercostal space from the mid-sternal line. Access to the valve annulus 10 through the apex 60 can be established using a larger diameter access port than is possible using percutaneous access methods. Thus, apical access to the heart 2 permits greater flexibility with respect to the types of devices and surgical methods that may be performed in the heart and great vessels.



FIGS. 2-6 show schematic views of exemplary embodiments of a valve access system 70 for delivering a replacement heart valve to a target site in a patient's heart 2. The valve access system 70 of the present invention allows for an antegrade as well as a retrograde approach to a target site within the heart 2. Exemplary target sites include native heart valves (e.g. pulmonary, mitral, aortic, and tricuspid) needing repair and/or replacement. While FIGS. 2-6 show the valve access system 70 traveling through the aortic arch, in alternative embodiments, the system 70 could exit the vasculature through the aorta and patient's body through a slit or opening in the wall of the aortic vessel.


According to the embodiment of FIG. 2, the valve access system 70 includes an implantation device 74 and is configured to deliver a prosthetic heart valve to a target site within a patient's heart 2. The implantation device 74 is configured to serve as a rail or track for providing access to the target site from a location outside the patient's body. According to one embodiment of the present invention, the implantation device 74 is a thin, flexible guidewire or a somewhat thicker wire, such as a stylet. According to an alternative embodiment of the present invention, the implantation device is a guide catheter. The guide catheter is adapted to provide passage to a variety of devices compatible with the valve access system of the present invention. According to one embodiment, the implantation device is reversibly lockable.


The implantation device 74 is of sufficient size and length to pass through a first opening in a patient's body (e.g., an aorta or a femoral artery access point), through a patient's aorta 54, and to exit through an access port 76 established in a patient's left ventricle 50 at or near the apex 60. The implantation device 74 then extends through a transthoracic port 78, which provides access through the patient's thoracoabdominal (e.g., intercostal) region and into the left ventricle 50 at or near the apex 60. The transthoracic port according to various exemplary embodiments is one of an introducer, trocar, or cannula, as is generally known in the art. According to one exemplary embodiment of the present invention, the port 78 includes one or more hemostasis valves or seals. The hemostasis valve or seal is adapted to provide a blood tight seal against any blood loss or leakage during the procedure, and can be used at the apex, at the aorta, or in both locations. The port 78 is configured to allow passage of the implantation device, catheter, or any tools or devices to be delivered to the target site using the implantation device, while at the same time providing a blood tight seal against blood loss or leakage.


According to one exemplary technique for introducing the access system 70, a physician establishes an access port into the patient's aorta or femoral artery using any of a variety of well-known techniques. The physician then establishes a second access point in the patient's intercostal region using the port 78. Using known imaging and guidance techniques, the physician then advances the implantation device 74 through the patient's aorta or arterial system to the aortic valve annulus 10. The physician then advances the implantation device 74 across the aortic valve annulus 10, through the left ventricle 50, and out of the heart through the port 78. At this point, the physician has established a continuous pathway allowing both retrograde (i.e., through the aorta or aortic arch) and antegrade (i.e., through the apex 60) access to the aortic valve annulus 10.


According to another exemplary embodiment, the implantation device 74 includes two portions. The physician introduces a first portion through the aorta or femoral artery to the aortic valve annulus 10 and introduces a second portion through the apex 60. According to various embodiments, the physician then couples the two portions together at or near the valve annulus 10 or the aortic root. In these embodiments, the implantation device 74 includes any of a variety of known structures for coupling the free ends to one another, so as to form a continuous rail or track. According to other embodiments, the physician employs any of a numerous variety of techniques known in the art to introduce the implantation device 74. According to various embodiments, the physician employs one or more of the following techniques to implant the device 74: optionally ballooning the native valve in one variant of the invention, or removing the native valve (e.g., by cutting the valve out of the annulus), optionally using an umbrella capture feature to catch any debris that may result from the cut, and implanting the device 74.


Once introduced, the implantation device 74 establishes a pathway between a first opening and second opening in a patient's body. The implantation device is left in place within the heart 2 to provide a tether or “rail” over which other tools or devices may be delivered. Additional tools and devices may be delivered along the rail using either a retrograde (i.e., via the aorta) or an antegrade (i.e., via the apex and left ventricle) approach. The implantation device 74 allows for one or more than one device to be delivered to the target site at the same time or substantially at the same time. This feature allows flexibility in delivery options and may increase the speed in the successive steps in the valve replacement procedure.


By way of further example, one tool or set of tools can be delivered through the access port from the aorta while a second tool or set of tools can be delivered through the access point in the left ventricle, along a single track spanning both points of access or along separate tracks, one for each access point. An aortic valve (which can be stenotic in many patients) cutter or remover is delivered through the access point in the aorta by a first physician or technician. The native stenotic valve (e.g., aortic valve) is excised, stored in a chamber of the cutter, and then the cutter assembly is removed through the aortic access point. A delivery system for an expandable valve prosthesis can be guided through the ventricular access port and be positioned in the ventricle ready for immediate insertion into position once the cutting operation has been completed. The delivery system can be optionally operated by a second physician or technician and be ready and waiting for deployment. It is appreciated that the speed with which both the cutting and the valve prosthesis deployment operations is greatly increased and the procedure time is greatly reduced using a combination antegrade and retrograde delivery approach. In this way the hemodynamic blood flow for the patient is maintained at an acceptable level while the patient is off-pump or partially off-pump. Similarly, it is appreciated that a variety of tools or modules (or portions thereof) can be guided either antegrade or retrograde along the guidewire.


In various exemplary embodiments of the invention, the cutter or native valve leaflet remover is sized and dimensioned to be delivered through the apex of the heart, while the delivery system including a heart valve prosthesis is sized and dimensioned for delivery through an access point on the aorta. In yet another variant of the invention, an access point can be established at any suitable point in the aortal tree.


By way of further example, a top portion of the cutter can be guided into cutting position along the guidewire along from the aortic access point, while a bottom portion of a cutter can be guided along the guidewire through the access point in the ventricle. The two portions meet at the native valve and perform the cutting and removal operation and then are each removed through the same access areas where they entered the patient.


By way of further example, other modules that can travel along the guidewire can include pumps for assisting in maintaining the patient's hemodynamic flow. The pumps can be positioned in various locations along the guidewire as needed. Other modules (e.g., a cutter or prosthesis delivery module) can then be guided over the pumps to perform their required operations.


As described, the valve access system 70 allows for delivery of a variety of devices to or near the aortic valve annulus 10. The system 70 may be used for example to introduce any of a variety of prosthetic heart valves, including, for example, stented and stentless tissue valves. The system 70 may also be used to introduce an imaging system to view all or a portion of a procedure. Imaging systems are well-known in the art and include, for example, transesophageal echo, transthoracic echo, intravascular ultrasound imaging (IVUS), and/or a radiopaque dye or contrast fluid. The imaging system may also include an optical viewing device, such as a fiber-optic camera.


The valve access system 70 allows for delivery of a variety of additional tools or devices, including, for example, the following: leaflet excision tools, leaflet capture devices, imaging devices, prosthetic heart valves, prosthetic valve delivery systems, blood-pump devices, inflation catheters and balloons, debris capture collapsible and expandable umbrellas, stenotic tissue debridement tools, markers located on the guidewire to assist in location of the guidewire at the appropriate location, centering balloons to center the guidewire in the desired orientation, and the like. In yet a further variant, an anti-embolization module is also added. According to various embodiments, the leaflet excision module includes a rigid portion having an actuator exerting sufficient force to cut through a calcified leaflet.


According to another embodiment of the present invention, the valve access system includes one or more interchangeable modules that are configured to be delivered along the implantation device 74 to the valve annulus 10. The implantation device 74 permits one or more modules to be in use at a given time, in series or in parallel. Depending upon the size of the module, an antegrade, retrograde, or combination antegrade and retrograde delivery approach may be chosen. As the apex 60 is not limited by the size constraints which are presented by percutaneous surgical methods, larger modules or devices may be delivered through the port 78. Smaller modules may continue to be delivered through the femoral artery approach or directly through a port or incision in the aorta. Ultimately either approach may be chosen at the discretion of one of skill in the art performing the procedure.


In yet another embodiment of the invention, all modules are de-aired, filled with a fluid (e.g., saline), or filled with an appropriate gas (e.g., carbon dioxide or nitrogen) prior to use. This process eliminates the risk of an embolism occurring through the introduction of any of the modules described below directly into the beating heart of the subject. According to various embodiments, the modules are de-aired using one of the techniques described in co-pending, commonly assigned U.S. patent application Ser. No. 11/851/528, filed on even date herewith, entitled “Fluid-Filled Delivery System for in Situ Deployment of Cardiac Valve Prostheses,” which is hereby incorporated by reference in its entirety.


According to the embodiment of the present invention shown in FIG. 3, the valve access system 70 includes a leaflet removal (i.e., excision) module 80, which may include a leaflet cutting tool 82. The leaflet removal module 80 includes a rigid portion having an actuator exerting sufficient force to cut through a calcified leaflet. The actuator can be hydraulically or mechanically actuated to provide sufficient force to cut through stenotic native valve tissue. In various embodiments, the actuator is spring actuated. In yet another variant, the actuator is gas actuated. Exemplary leaflet removal or cutting tools are shown and described in U.S. Pat. No. 5,304,189, U.S. Pat. No. 5,370,685, and U.S. Publication 2006/0271081, each of which are incorporated herein by reference.


According to yet a further embodiment of the present invention, as is also shown in FIG. 3, the valve access system 70 also includes a leaflet capture device 84. The leaflet capture device 84 captures the removed portion or portions of the leaflet upon excision and traps any debris from the removal or decalcification of the leaflets. The capture device 84 entraps and contains the debris or excised portions. The capture device permits removal of the debris from the patient's heart 2.



FIGS. 4A and 4B show another embodiment of the valve access system 70 of the present invention. As shown in FIG. 4A, the system 70 includes an expandable prosthetic heart valve 90 retained in a collapsed configuration within a delivery sheath 94. As described previously, the heart valve 90 can be crimped onto the delivery system 70 under water, such that the sheath is fluid filled to prevent embolism. Exemplary expandable prosthetic heart valves are shown and described in U.S. Publication 2006/0178740 and U.S. Publication 2005/0197695, both of which are incorporated herein by reference. An exemplary delivery system for an expandable prosthetic valve is shown and described in commonly-assigned, co-pending U.S. application Ser. No. 11/612,980, entitled “Instrument and Method for In-Situ Deployment of Cardiac Valve Prosthesis”, which is incorporated herein by reference. As shown in FIG. 4A, the prosthetic valve 90 has been delivered over the implantation device 74 to a target site within or near the aortic valve annulus 10 via an access port established at or near the apex 60. As shown, in FIG. 4B, the delivery sheath 94 can be retracted allowing the expandable prosthetic heart valve 90 to transition from a collapsed configuration to an expanded configuration, after which the implantation device 74 can be removed. According to other embodiments, the delivery sheath 94 could be introduced in a retrograde manner through the aorta or optionally through the aortic arch.



FIG. 5 shows an embodiment of the valve access system 70 of the present invention, which includes two interchangeable modules. As shown in FIG. 5, the valve access system 70 includes an implantation device 74 and a first module being delivered using an antegrade approach and a second module being delivered using a retrograde approach. According to one embodiment of the present invention, the modules have different functionalities. For example, in various embodiments, the first module is a leaflet cutter 80 and the second module is an expandable prosthetic valve 90 contained within a delivery sheath 94. After the leaflets have been excised from the valve annulus, the expandable prosthetic valve 90 can be quickly delivered and released to expand within the valve annulus. This configuration can help reduce the time that a patient's heart is beating, without a functioning valve in place, by allowing a physician to deliver both a valve removal device and a valve delivery device at or near the valve annulus 10, before actually removing the valve leaflets. The configuration is thus helpful for off-pump, beating heart prosthetic valve replacement.


According to yet a further embodiment of the present invention, as shown in FIG. 6, the valve access system 70 includes a blood-pumping device 100. For example, the blood pumping device is a left ventricular assist device (LVAD) known to those of skill in the art. Exemplary LVADs are shown and described in U.S. Pat. No. 7,144,364, which is incorporated herein by reference. The LVAD can be delivered using either an antegrade or a retrograde approach along the pathway established by the implantation device 74. The LVAD is then delivered to a target site within the left ventricle or the aorta.


In yet another variant of the invention, two distinct mechanically unconnected tracks are used upon which two mechanically unconnected modules are utilized. In this variant, a first module is configured to be delivered from a first opening in a patient's aortic tree and through the patient's aorta. One or more of the modules described herein may be used. A second module is configured to be delivered through an opening in a ventricle. Again, one or more modules described herein may be used. As with the other embodiments described herein, the fact that two simultaneous or nearly simultaneous access points are used on the patient allows for speed of native valve removal and implantation of a new prosthesis.


Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.

Claims
  • 1. An access system for implanting an expandable heart valve prosthesis at an aortic valve annulus in a patient's heart, the access system comprising: a transthoracic access port, including one or more hemostasis valves or seals, that are configured to be used at or near an opening in a left ventricle, anda second port, including one or more hemostasis valves or seals, that are configured to be used at or near an aortic wall opening;a guidewire having a sufficient size and length to extend through a first opening in the patient's body, through the opening in the patient's aortic wall, through the patient's aorta, through the valve annulus in the patient's heart, through the opening in the left ventricle at or near an apex of the patient's heart, and through an opening in the patient's thoracoabdominal region, the guidewire being structurally continuous and having a sufficient length to extend continuously between the transthoracic access port and the second port;a first module configured for retrograde delivery along the guidewire through the first opening and through the aortic wall opening toward the valve annulus; anda second module, not mechanically coupled to the first module, the second module configured for antegrade delivery along the guidewire through the thoracoabdominal region opening and the opening in the ventricle toward the valve annulus;wherein the first or second module is selected from a group consisting of a ballooning module, a leaflet cutting or removal module, an annulus sizing module, an expandable valve prosthesis module, a pump module, and a debris catching module.
  • 2. The access system of claim 1, wherein the leaflet cutting or removal module comprises a rigid portion having an actuator exerting sufficient force to cut through a calcified leaflet.
  • 3. The access system of claim 1, wherein the guidewire is a stylet.
  • 4. The access system of claim 1, wherein the modules can be delivered to the target location within the heart using either of an antegrade approach or a retrograde approach.
  • 5. The access system of claim 1, wherein the guidewire is bendable and steerable.
  • 6. The access system of claim 5 in which the guidewire is reversibly lockable.
  • 7. The access system of claim 1, wherein the transthoracic access port is selected from a group comprising: an introducer, a trocar and a cannula.
  • 8. The access system of claim 1, wherein at least one of the first or second module includes an imaging system to view all or a portion of a procedure.
  • 9. The access system of claim 8, wherein the imaging system includes a device selected from the group comprising: a transesophogeal echo, transthoracic echo, intravascular ultrasound imaging, and/or a radiopaque dye or contrast fluid.
  • 10. The access system of claim 9, wherein the imaging system also includes an optical viewing device.
  • 11. The access system of claim 1, wherein the first module comprises a leaflet cutter and the second module comprises an expandable prosthetic heart valve contained within a delivery sheath.
  • 12. The access system of claim 1, wherein at least one of the first and second modules includes at least one pump for assisting in maintaining the patient's hemodynamic flow, with the at least one pump being positionable at various locations along the guidewire.
  • 13. An access system for implanting an expandable heart valve prosthesis at an aortic valve annulus in a patient's heart, the access system comprising: a guidewire having a sufficient size and length to extend through a first opening in the patient's body, through an opening or slit in the patient's aortic wall, through the patient's aorta, through the valve annulus in the patient's heart, through an opening in a left ventricle at or near the apex of the patient's heart, and through an opening in the patient's thoracoabdominal region, the guidewire being structurally continuous;a first module configured for retrograde delivery along the guidewire through the first opening and through the aortic wall opening toward the valve annulus; anda second module, not mechanically coupled to the first module, the second module configured for antegrade delivery along the guidewire through the thoracoabdominal region opening and the opening in the ventricle toward the valve annulus;anda transthoracic access port, including one or more hemostasis valves or seals, that are configured to be used at or near the ventricle opening, anda second port, including one or more hemostasis valves or seals, that are configured to be used at or near the aortic wall opening;wherein the first or second module is selected from a group consisting of a ballooning module, a leaflet cutting or removal module, an annulus sizing module, an expandable valve prosthesis module, a pump module, and a debris catching module, wherein the first module includes a top portion of the leaflet cutting or removal module and the second module includes a bottom portion of the leaflet cutting or removal module, wherein the top and bottom portions can be guided to and meet at the valve annulus to perform a cutting and removal operation.
  • 14. An access system for implanting an expandable heart valve prosthesis at an aortic valve annulus in a patient's heart, the access system comprising: a guidewire having a sufficient size and length to extend through a first opening in the patient's thoracoabdominal region, through an opening in a left ventricle at or near the apex of the heart, through the aortic valve annulus, through an opening or slit in the patient's aortic wall, and through an opening in the patient's body at or near the aorta, the guidewire being structurally continuous;a first module configured for retrograde delivery along the guidewire through the first opening and the aortic wall opening toward the valve annulus;a second module, not mechanically coupled to the first module, the second module configured for antegrade delivery along the guidewire through the thoracoabdominal region opening and the opening in the ventricle toward the valve annulus,wherein the first or second module is selected from a group consisting of a ballooning module, a leaflet cutting or removal module, an annulus sizing module, an expandable valve prosthesis module, a pump module and a debris catching module; anda transthoracic access port, including one or more hemostasis valves or seals, that are configured to be used at or near the ventricular opening, and a second port, including one or more hemostasis valves or seals, that are configured to be used at or near the aortic wall opening.
US Referenced Citations (294)
Number Name Date Kind
3671979 Moulopoulos Jun 1972 A
4011947 Sawyer Mar 1977 A
4056854 Boretos et al. Nov 1977 A
4477930 Totten et al. Oct 1984 A
4601706 Aillon Jul 1986 A
4624822 Arru et al. Nov 1986 A
4684364 Sawyer et al. Aug 1987 A
4722725 Sawyer et al. Feb 1988 A
4732152 Wallsten et al. Mar 1988 A
4758151 Arru et al. Jul 1988 A
4777951 Cribier et al. Oct 1988 A
4784644 Sawyer et al. Nov 1988 A
4994077 Dobben Feb 1991 A
5057092 Webster, Jr. Oct 1991 A
5084151 Vallana et al. Jan 1992 A
5123919 Sauter et al. Jun 1992 A
5133845 Vallana et al. Jul 1992 A
5181911 Shturman Jan 1993 A
5201757 Heyn et al. Apr 1993 A
5287848 Cubb Feb 1994 A
5304189 Goldberg et al. Apr 1994 A
5312393 Mastel May 1994 A
5332402 Teitelbaum Jul 1994 A
5370684 Vallana et al. Dec 1994 A
5370685 Stevens Dec 1994 A
5387247 Vallana et al. Feb 1995 A
5397351 Pavcnik et al. Mar 1995 A
5411552 Andersen et al. May 1995 A
5423886 Arru et al. Jun 1995 A
5433723 Lindenberg et al. Jul 1995 A
5445646 Euteneuer et al. Aug 1995 A
5545214 Stevens Aug 1996 A
5554185 Block et al. Sep 1996 A
5556414 Turi Sep 1996 A
5662712 Pathak et al. Sep 1997 A
5693083 Baker et al. Dec 1997 A
5766151 Valley et al. Jun 1998 A
5772693 Brownlee Jun 1998 A
5782811 Samson et al. Jul 1998 A
5824064 Taheri Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5849005 Garrison et al. Dec 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5871489 Ovil Feb 1999 A
5925063 Khosravi Jul 1999 A
5951600 Lemelson Sep 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5980570 Simpson Nov 1999 A
6010530 Goicoechea Jan 2000 A
6010531 Donlon et al. Jan 2000 A
6019756 Mueller et al. Feb 2000 A
6019790 Holmberg et al. Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6030360 Biggs Feb 2000 A
6090099 Samson et al. Jul 2000 A
6106497 Wang Aug 2000 A
6125852 Stevens et al. Oct 2000 A
6139572 Campbell et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6174307 Daniel et al. Jan 2001 B1
6251093 Valley et al. Jun 2001 B1
6299638 Sauter Oct 2001 B1
6309382 Garrison et al. Oct 2001 B1
6346071 Mussivand Feb 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6416474 Penner et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6482228 Norred Nov 2002 B1
6572642 Rinaldi et al. Jun 2003 B2
6582462 Andersen et al. Jun 2003 B1
6607553 Healy et al. Aug 2003 B1
6641558 Aboul-Hosn et al. Nov 2003 B1
6645197 Garrison et al. Nov 2003 B2
6645220 Huter et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6685739 DiMatteo et al. Feb 2004 B2
6726648 Kaplon et al. Apr 2004 B2
6726651 Robinson et al. Apr 2004 B1
6726712 Raeder Devens et al. Apr 2004 B1
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6767362 Schreck Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6805711 Quijano et al. Oct 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof et al. Dec 2004 B1
6875231 Anduiza et al. Apr 2005 B2
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6913618 Denardo et al. Jul 2005 B2
6945957 Freyman Sep 2005 B2
6964673 Tsugita et al. Nov 2005 B2
6974464 Quijano et al. Dec 2005 B2
6981942 Khaw et al. Jan 2006 B2
6991646 Clerc et al. Jan 2006 B2
7001423 Euteneuer et al. Feb 2006 B2
7018406 Seguin et al. Mar 2006 B2
7018408 Bailey et al. Mar 2006 B2
7041132 Quijano et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7077801 Haverich Jul 2006 B2
7101396 Artof et al. Sep 2006 B2
7144364 Barbut et al. Dec 2006 B2
7156872 Strecker Jan 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7201761 Woolfson et al. Apr 2007 B2
7329279 Salahieh et al. Feb 2008 B2
7338467 Lutter Mar 2008 B2
7338520 Bailey et al. Mar 2008 B2
7374571 Pease et al. May 2008 B2
RE40377 Williamson, IV et al. Jun 2008 E
7544206 Cohn Jun 2009 B2
7556646 Yang et al. Jul 2009 B2
7591843 Escano et al. Sep 2009 B1
7618432 Pedersen et al. Nov 2009 B2
7635386 Gammie Dec 2009 B1
7708775 Rowe et al. May 2010 B2
7896915 Guyenot et al. Mar 2011 B2
7993392 Rihhini et al. Aug 2011 B2
8057539 Ghione et al. Nov 2011 B2
8070799 Righini et al. Dec 2011 B2
8114154 Righini et al. Feb 2012 B2
20010002445 Vesely May 2001 A1
20010007956 Letac et al. Jul 2001 A1
20010010017 Letac et al. Jul 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20010044591 Stevens et al. Nov 2001 A1
20020029075 Leonhardt Mar 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020045846 Kaplon et al. Apr 2002 A1
20020058995 Stevens May 2002 A1
20020099431 Armstrong et al. Jul 2002 A1
20020107531 Schreck et al. Aug 2002 A1
20020117264 Rinaldi et al. Aug 2002 A1
20020123802 Snyders Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020198594 Schreck Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030033000 DiCaprio et al. Feb 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030109924 Cribier Jun 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030163194 Quijano et al. Aug 2003 A1
20030191521 Denardo et al. Oct 2003 A1
20030191528 Quijano et al. Oct 2003 A1
20040034411 Quijano et al. Feb 2004 A1
20040039371 Tockman et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040055606 Hendricksen et al. Mar 2004 A1
20040078072 Tu et al. Apr 2004 A1
20040093060 Seguin et al. May 2004 A1
20040093063 Wright et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040127848 Freyman Jul 2004 A1
20040147993 Westlund et al. Jul 2004 A1
20040186563 Lobbi Sep 2004 A1
20040215333 Duran et al. Oct 2004 A1
20040236170 Kim Nov 2004 A1
20040249413 Allen et al. Dec 2004 A1
20050075584 Cali Apr 2005 A1
20050075712 Biancucci et al. Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050075726 Svanidze et al. Apr 2005 A1
20050075728 Nguyen et al. Apr 2005 A1
20050075729 Nguyen et al. Apr 2005 A1
20050075730 Myers et al. Apr 2005 A1
20050075731 Artof et al. Apr 2005 A1
20050080476 Gunderson et al. Apr 2005 A1
20050096993 Pradhan et al. May 2005 A1
20050104957 Okamoto et al. May 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Salahieh et al. Jun 2005 A1
20050137693 Haug et al. Jun 2005 A1
20050137694 Salahieh et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050137699 Salahieh et al. Jun 2005 A1
20050137701 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050165480 Jordan et al. Jul 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050240200 Bergheim Oct 2005 A1
20050251251 Cribier Nov 2005 A1
20050267493 Schreck et al. Dec 2005 A1
20050278010 Richardson Dec 2005 A1
20060004436 Amarant et al. Jan 2006 A1
20060004439 Spenser et al. Jan 2006 A1
20060020333 Lashinski et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060025844 Majercak et al. Feb 2006 A1
20060030922 Dolan Feb 2006 A1
20060063199 Elgebaly et al. Mar 2006 A1
20060064054 Sakakine et al. Mar 2006 A1
20060074271 Cotter Apr 2006 A1
20060074484 Huber Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060095025 Levine et al. May 2006 A1
20060100639 Levin et al. May 2006 A1
20060135962 Kick et al. Jun 2006 A1
20060142838 Molaei et al. Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060195184 Lane et al. Aug 2006 A1
20060229659 Gifford et al. Oct 2006 A1
20060241656 Starksen Oct 2006 A1
20060271081 Realyvasquez Nov 2006 A1
20060276775 Rosenberg et al. Dec 2006 A1
20070010850 Balgobin et al. Jan 2007 A1
20070027534 Bergheim et al. Feb 2007 A1
20070032850 Ruiz et al. Feb 2007 A1
20070055357 Pokorney et al. Mar 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070100302 Dicarlo et al. May 2007 A1
20070100356 Lucatero et al. May 2007 A1
20070100440 Figulla et al. May 2007 A1
20070112355 Salahieh et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070118207 Amplatz et al. May 2007 A1
20070118209 Strecker May 2007 A1
20070156225 George et al. Jul 2007 A1
20070162100 Gabbay Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070173861 Strommer et al. Jul 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070203561 Forster et al. Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070219630 Chu Sep 2007 A1
20070250097 Weitzner et al. Oct 2007 A1
20070265702 Lattouf Nov 2007 A1
20080021546 Patz et al. Jan 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080097595 Gabbay Apr 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080147160 Ghione et al. Jun 2008 A1
20080147180 Ghione et al. Jun 2008 A1
20080147181 Ghione et al. Jun 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080147188 Steinberg Jun 2008 A1
20080183097 Leyde et al. Jul 2008 A1
20080208216 Cerier Aug 2008 A1
20080262507 Righini et al. Oct 2008 A1
20090069886 Suri et al. Mar 2009 A1
20090069887 Righini et al. Mar 2009 A1
20090069889 Suri et al. Mar 2009 A1
20090069890 Suri et al. Mar 2009 A1
20090105794 Ziarno et al. Apr 2009 A1
20090118580 Sun et al. May 2009 A1
20090157174 Yoganathan et al. Jun 2009 A1
20090164004 Cohn Jun 2009 A1
20090164006 Seguin et al. Jun 2009 A1
20090171363 Chocron Jul 2009 A1
20090171456 Kveen et al. Jul 2009 A1
20090177275 Case Jul 2009 A1
20090228093 Taylor et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240326 Wilson et al. Sep 2009 A1
20090254165 Tabor et al. Oct 2009 A1
20090281609 Benichou et al. Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20100191326 Alkhatib Jul 2010 A1
20100292782 Giannetti et al. Nov 2010 A1
20100292783 Giannetti et al. Nov 2010 A1
20100292784 Giannetti et al. Nov 2010 A1
20120053684 Righini et al. Mar 2012 A1
20130123915 Giannetti et al. May 2013 A1
Foreign Referenced Citations (68)
Number Date Country
19546692 Jun 1997 DE
29919625 Feb 2000 DE
19857887 Jul 2000 DE
19857887 May 2005 DE
0133420 Feb 1988 EP
0155245 May 1990 EP
0592410 Oct 1995 EP
0512359 Dec 1996 EP
0515324 Dec 1996 EP
0850607 Jul 1998 EP
1057460 Dec 2000 EP
1059271 Dec 2000 EP
1088529 Apr 2001 EP
1356763 Oct 2003 EP
1356793 Oct 2003 EP
0852481 Feb 2004 EP
1440671 Jul 2004 EP
1088529 Jun 2005 EP
0955895 Aug 2005 EP
1488735 Jun 2007 EP
1212989 Jan 2008 EP
1653884 Jun 2008 EP
1935377 Jun 2008 EP
1955643 Aug 2008 EP
1986579 Nov 2008 EP
1570809 Jan 2009 EP
2033581 Mar 2009 EP
2033597 Mar 2009 EP
2828091 Feb 2003 FR
WO9511055 Apr 1995 WO
9724989 Jul 1997 WO
9817202 Apr 1998 WO
9829057 Jul 1998 WO
WO9853761 Dec 1998 WO
WO 9904728 Feb 1999 WO
9956665 Nov 1999 WO
WO 0018303 Apr 2000 WO
0041652 Jul 2000 WO
WO 0041525 Jul 2000 WO
WO 01021244 Mar 2001 WO
0162189 Aug 2001 WO
0164137 Sep 2001 WO
0176510 Oct 2001 WO
0241789 May 2002 WO
0247575 Jun 2002 WO
02076348 Oct 2002 WO
03003943 Jan 2003 WO
03094797 Nov 2003 WO
WO2004019825 Mar 2004 WO
WO2004028399 Apr 2004 WO
2004089253 Oct 2004 WO
WO 2005046525 May 2005 WO
WO 2005065200 Jul 2005 WO
WO 2005096993 Oct 2005 WO
2005104957 Nov 2005 WO
2005104957 Nov 2005 WO
2006054107 May 2006 WO
2006063199 Jun 2006 WO
2006063199 Jun 2006 WO
WO 2006086135 Aug 2006 WO
2006116558 Nov 2006 WO
WO 2006135551 Dec 2006 WO
WO 2006138173 Dec 2006 WO
WO2007021708 Feb 2007 WO
WO 2007071436 Jun 2007 WO
WO 2007076463 Jul 2007 WO
WO 2008097589 Aug 2008 WO
WO 2008125153 Oct 2008 WO
Non-Patent Literature Citations (27)
Entry
European Search Report and Search Opinion of European Patent Application No. 06126556.7, dated Jun. 27, 2007.
Huber et al., “Direct-Access Valve Replacement: A Novel Approach for Off-Pump Valve Implantation Using Valved Stents,” Journal of the American College of Cardiology, 46(2): 366-370, Jul. 19, 2002.
U.S. Appl. No. 11/612,968, filed Dec. 19, 2006.
U.S. Appl. No. 11/612,972, filed Dec. 19, 2006.
U.S. Appl. No. 11/612,974, filed Dec. 19, 2006.
U.S. Appl. No. 11/612,980, filed Dec. 19, 2006.
U.S. Appl. No. 11/851,523, filed Sep. 7, 2007.
U.S. Appl. No. 11/851,528, filed Sep. 7, 2007.
Huber et al., “Direct-Access Valve Replacement: A Novel Approach for Off-Pump Valve Implantation Using Valved Stents”, Journal of the American College of Cardiology, pp. 366-370, vol. 46, No. 2, Jul. 19, 2005, ISSN: 0735-1097/05, published on-line Jul. 5, 2005.
Righini et al., U.S. Appl. No. 11/612,980, filed Dec. 19, 2006, “Instrument and Method for in Situ Deployment of Cardiac Valve”.
Righini et al., U.S. Appl. No. 11/851,528, filed Sep. 7, 2007, “Fluid-Filled Delivery System for in Situ Deployment of Cardiac Valve Prostheses”.
European Search Report Issued in EP Application No. 09160183, dated Oct. 2, 2009, 6 pages.
European Search Report Issued in EP Application No. 09160186, dated Oct. 6, 2009, 5 pages.
European Search Report Issued in EP Application No. 07115951, dated Sep. 24, 2009, 8 pages.
Extended European Search Report issued in EP Application 06126552, dated Jun. 6, 2007, 7 pages.
Extended European Search Report issued in EP Application 09158822, dated Sep. 9, 2009, 5 pages.
Ho, Paul C., “Percutaneous aortic valve replacement: A novel design of the delivery and deployment system”, Minimally Invasive Therapy, 2008; 17:3; 190-194.
European Search Report and Search Opinion of European Patent Application No. 07115960.2, dated Jan. 24, 2008.
European Search Report Issued in EP 09160184 dated Oct. 22, 2009.
European Search Report issued in EP Application 08163752, dated Dec. 29, 2008.
Extended European Search Report issued in EP Application 06126556, dated Jul. 6, 2007, 13 pages.
Extended European Search Report issued in EP Application 09158822, dated Sep. 29, 2009, 5 pages.
Huber et al., “Direct-Access Valve Replacement: A Novel Approach for Off-Pump Valve Implantation Using Valved Stents”, Journal for the American College of Cardiology, pp. 366-370, vol. 46, No. 2, Jul. 19, 2005, ISSN: 0735-1097/05, published on-line Jul. 5, 2005.
Partial European Search Report issued in EP App No. 06126556, mailed Apr. 16, 2007, 6 pages.
European Search Report issued in EP Application No. 08159301, mailed Dec. 30, 2008, 6 pages.
Partial European Search Report issued in EP Application No. 10155332, dated Jun. 9, 2011, 7 pages.
European Search Report issued in EP 11182402, mailed Nov. 16, 2011, 5 pages.
Related Publications (1)
Number Date Country
20090069886 A1 Mar 2009 US